Virtu Financial LLC Agios Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$27.55 - $48.83 $136,648 - $242,196	4,960 New	4,960 $214,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $173,884 - $241,330	-4,148 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$52.06 - $61.27 $215,944 - $254,147	4,148 New	4,148 $229,000
Q2 2019 Aug 13, 2019	SELL	$46.17 - $68.1 $240,915 - $355,345	-5,218 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$45.92 - $67.67 $239,610 - $353,102	5,218 New	5,218 $352,000
Q2 2018 Jul 30, 2018	SELL	$73.22 - $99.55 $482,373 - $655,835	-6,588 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$73.22 - $99.55 $482,373 - $655,835	6,588 New	6,588 $555,000

231

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.85B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.